The Surprising Buy Case For Reckitt Benckiser Group plc

Royston Wild looks at a little-known share price catalyst for Reckitt Benckiser Group plc (LON: RB).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am looking at an eye-opening reason why stunning growth in key regional markets are set to drive shares in Reckitt Benckiser (LSE: RB) (NASDAQOTH: RBGLY.US) higher.

Developing market growth rates to sail higher

Reckitt Benckiser — which operates across 200 countries across the globe — has identified 16 so-called ‘Powermarkets’ from where it can turbocharge earnings, a strategy that is increasingly paying off in huge dividends for the Slough firm.

The business announced in July’s half-yearly report that group net revenues advanced 7% in the first six months of 2013, to £4.99bn, while like-for-like growth ticked 6% higher from the corresponding 2012 period. These improved revenues drove adjusted operating profit 3% higher to £1.16bn.

And the financial report reiterated the galloping progress that Reckitt Benckiser continues to make in emerging markets. Revenues from Europe and North America (ENA), on a constant currencies basis, nudged just 4% higher in January-June, to £2.45bn. By comparison, turnover from its so-called ‘LAPAC’ region — or Latin America, Asia Pacific, Australasia and China — leapt 13% over the same period to £1.28bn. Revenues from RUMEA (Russia, the Middle East and Africa) rose by a more modest 5% to £703m.

Sales from these lucrative emerging markets now account for 44.8% of group revenues, up from 44.2% in the first half of 2012. By comparison, group sales from Reckitt Benckiser’s traditional Western Markets fell to 55.2% in January-June from 55.8% previously.

The household goods giant’s aggressive drive into developing markets is helped by the quality and stellar reputation of its so-called ‘Powerbrands.’ From health products such as Nurofen and Durex, kitchen staples like Finish and Calgon and home cleaning and maintenance labels Dettol and Air Wick, Reckitt Benckiser boasts an enviable stable of go-to products that can be found throughout most homes.

Reckitt Benckiser has also been extremely active on the M&A scene in recent times to build exposure to lucrative growth markets, and has spent £413m in China and Latin America alone over the past year to expand its presence in these areas.

And just this week, group head Rakesh Kapoor hinted that more acquisitions could be just around the corner. The chief executive commented at the Reuters Consumer and Retail Summit that he expects the highly fragmented consumer health industry to  undergo waves of consolidation in the coming years, and that Reckitt Benckiser has the spending power to be a significant dealmaker. I fully expect the company to make good on this statement, particularly in emerging markets in order to supplement already healthy organic growth rates.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Royston does not own shares in Reckitt Benckiser.

More on Investing Articles

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »

Investing Articles

Investing £5 a day could help me build a second income of £329 a month!

This Fool explains how £5 a day, or one less takeaway coffee, could help her build a monthly second income…

Read more »